Portland, Oregon, United States The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the 3x5 Partners, startups are often financed by RiverVest, Roche Venture Fund, Novo Ventures. The meaningful sponsors for the fund in investment in the same round are RiverVest, Roche Venture Fund, Samsara BioCapital.
The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Care, Food Processing. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Good Therapeutics, Allakos.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2018.
| Fund Name | Location |
| Angel Effect | Istanbul, Kurucesme, Turkey |
| Asia Phoenix Investments | - |
| CMA CGM | France, Marseille, Provence-Alpes-Cote d'Azur |
| Energizer | Missouri, St Louis, United States |
| Peapack-Gladstone Bank | Bedminster, New Jersey, United States |
| ProofSystems | - |
| RapidShare Entertainment | Cham, Switzerland, Zug |
| Rockpoint Capital | Boston, Massachusetts, United States |
| Zonff Partners | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Koya Medical | $26M | 03 Feb 2022 | Oakland, California, United States | ||
Good Therapeutics | $8M | 30 Dec 2021 | Seattle, Washington, United States | ||
Arch Oncology | $105M | 27 Apr 2021 | California, United States | ||
Amplyx Pharmaceuticals | $53M | 19 May 2020 | San Diego, California, United States | ||
InterVene | $15M | 25 Jun 2019 | South San Francisco, California, United States | ||
Allakos | $100M | 13 Dec 2017 | California, United States | ||
Fishpeople Seafood | $12M | 06 Jun 2017 | Portland, Oregon, United States |
– Claros Technologies is a St. Paul, Minn.-based advanced materials company.
– The company closed an $5m Series A funding round.
– The round was led by 3×5 Partners.
– The new investment will be used to expand the applications of their technology at the scale required to address problems for which the world needs immediate solutions.
– Arch Oncology, a clinical-stage immuno-oncology company, has closed a $105m Series C financing co-led by Eventide Asset Management, Cowen Healthcare Investments and current investor 3×5 Partners.
– New investors in the round included Adage Capital Management, Point72 Asset Management, Avego Healthcare Capital, FMB Research and Broadfin Holdings.
– The company’s existing investors, including Roche Venture Fund, RiverVest Venture Partners, and Lightchain also participated in the round.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Koya Medical | $26M | 03 Feb 2022 | Oakland, California, United States | ||
Good Therapeutics | $8M | 30 Dec 2021 | Seattle, Washington, United States | ||
Arch Oncology | $105M | 27 Apr 2021 | California, United States | ||
Amplyx Pharmaceuticals | $53M | 19 May 2020 | San Diego, California, United States | ||
InterVene | $15M | 25 Jun 2019 | South San Francisco, California, United States | ||
Allakos | $100M | 13 Dec 2017 | California, United States | ||
Fishpeople Seafood | $12M | 06 Jun 2017 | Portland, Oregon, United States |
